Lisa Alderson

From Wikitia
Jump to navigation Jump to search
Lisa Alderson
Add a Photo
NationalityAmerican
CitizenshipUnited States of America
Occupation
  • Entrepreneur
  • advocate

Lisa Alderson is an entrepreneur and advocate for the advancement of genomic medicine to detect and prevent disease.[1] She is an entrepreneur in residence at Illumina Ventures.[2] Previously, Lisa was Co-founder and CEO of Genome Medical, a telegenomics company.[3] Before that, Lisa was chief commercial officer and chief strategy office of Invitae, a genetic testing company.[2][4] She holds an MBA from Harvard Business School.[5]

Career

Lisa entered the field of cancer genomics in 2000.[1] In 2016 she co-founded Genome Medical, a technology company that provides consults for doctors and patients on genetic test results, with Randy Scott and Harvard Medical School geneticist Robert Green.[3] In 2017, the company launched with a Series A financing of $12 million from Canaan Partners, Illumina Ventures, HealthInvest Equity Partners, and Flywheel Ventures.[6] While Lisa was CEO, Genome Medical raised over $120 million in financing[7]. In 2021 the company acquired GeneMatters, a Minneapolis company offering virtual genetic consults, to expand its reach in the U.S.[8] In 2022, Genome Medical was named a “Best Startup Employer” by Forbes[9] and in 2023 received a Medtech Breakthrough Award in the category of genomics.[10]

In 2022, Lisa stepped down as CEO of Genome Medical and joined Illumina Ventures as an entrepreneur-in-residence.[2] She also serves on the board of the Kidney Cancer Association.[1]

Recognition

Lisa has been invited to speak at healthcare and technology conferences on the topics of genomics and genomic medicine, including HLTH 2019, Precision World Medicine Conference, Webit, Web Summit, The Oliver Wyman Health Innovation Summit, and the Harvard Business School's Annual Healthcare Conference.[11][12][13][14]

Personal life

Lisa is married and lives in Monterey, CA with her husband and their two children.[1]

References

  1. 1.0 1.1 1.2 1.3 Wetmore, Erin (2020-08-05). "Spotlight: Lisa Alderson of the KCA's Board of Directors". Kidney Cancer Association. Retrieved 2023-07-13.
  2. 2.0 2.1 2.2 "People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More". GenomeWeb. 2023-01-27. Retrieved 2023-07-13.
  3. 3.0 3.1 Farr, Christina (2017-05-23). "A big problem with genetic testing is figuring out what the results mean - start-up Genome Medical aims to help". CNBC. Retrieved 2023-07-13.
  4. Wosen, Jonathan (2023-01-16). "Invitae's new CEO on why the genetic testing firm stopped chasing 'volume at all costs'". STAT. Retrieved 2023-07-13.
  5. "2019 Speakers". HBS Healthcare Annual Conference. 2019-11-07. Retrieved 2023-07-13.
  6. Preston, Juliet (2017-05-25). "Can telehealth solve America's genetic counselor shortage?". MedCity News. Retrieved 2023-07-13.
  7. Leuty, Ron (2019-06-11). ""It's a genetic jungle out there -- and this Peninsula company just landed $23M to guide patients through it."". www.bizjournals.com. Retrieved 2023-07-13.
  8. Park, Andrea (2021-08-30). ""Genome Medical plots growth spurt with back-to-back $60M venture raise, GeneMatters acquisition"". FierceBiotech. Retrieved 2023-07-13.
  9. "Genome Medical | Company Overview & News". Forbes. Retrieved 2023-07-13.
  10. "2023 Winners". MedTech Breakthrough. Retrieved 2023-07-13.
  11. "Lisa Alderson". HLTH. 2019-01-03. Retrieved 2023-07-13.
  12. "Genetic Screening for Population Health is Becoming a Reality Session Chair: Lisa Alderson, Genome Medical". PMWC Precision Medicine World Conference. Retrieved 2023-07-13.
  13. "Lisa Alderson, Genome Medical / CEO & Co-Founder | WEBIT.FESTIVAL Europe 2020". www.webit.org. Retrieved 2023-07-13.
  14. "DNA disruption: What genomics needs next". Web Summit YouTube Channel. 2018-11-08.

External links

Add External links

This article "Lisa Alderson" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.